Cargando...
Rationale for STING-targeted cancer immunotherapy
The efficacy of checkpoint inhibitor therapy illustrates that cancer immunotherapy, which aims to foster the host immune response against cancer to achieve durable anticancer responses, can be successfully implemented in a routine clinical practice. However, a substantial proportion of patients does...
Gardado en:
| Publicado en: | Eur J Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5362072/ https://ncbi.nlm.nih.gov/pubmed/28219022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2016.12.028 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|